Novo Nordisk (NVO) reported better-than-expected operating profits for Q4 2024 on Wednesday, thanks mainly to its GLP-1 drugs, including its popular weight loss therapy Wegovy, which added DKK 19.9B ...

After falling behind Taiwan Semiconductor Manufacturing (NYSE: TSM) in process technology, Intel embarked on an ambitious and ...

Stifel Financial Corporation (SF) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $2.23, compared to the forecasted $1.96. This 13.78% ...

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...

Despite growth in ads, Alphabet’s shares sank in pre-market trading as investors digested the company’s revenue miss.

TotalEnergies reported higher-than-expected fourth-quarter earnings, driven by strong performance in its LNG business, ...

The fund outperformed the Russell 2000 Growth Index benchmark in the fourth quarter. The fund fared better than its benchmark ...

Marsh attributed the decline to increasing competition in the commercial property insurance market, stabilization in financial lines, moderation of casualty rate increases, and further reductions in ...

LONDON/COPENHAGEN (Reuters) -Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow ...

Spanning inspiration from different decades, and a move away from micro-trends, here’s what to expect on the runways for the ...

Equinor on Wednesday posted slightly higher-than-expected profits for the final quarter of 2024, while raising its oil and ...

YouTube continues to be the dominant player in ad-supported streaming, reporting Q4 advertising revenue of $10.5 billion, up from $9.2 billion a year ago, and surging past $10B in a quarter for the ...